Quimi Daphne (CIK 0001543031)

Latest company ownership

Shares held
398,532
Last filed at
Jan 19, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q4 2025Q4
Shares held
5,000
Last filed at
Sep 16, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
5,000
Last filed at
May 16, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 12, 2024 Sep 16, 2024 Century Therapeutics, Inc. Director Buy 90.0 +5,000 100.00% ✗ $7.7K
May 14, 2024 May 16, 2024 Amylyx Pharmaceuticals, Inc. Director Buy 90.0 +5,000 100.00% ✗ $9.4K
Jan 17, 2023 Jan 19, 2023 AMICUS THERAPEUTICS, INC. CFO Sell 41.3 -11,923 -2.90% ✓ $152.4K
Jan 11, 2023 Jan 13, 2023 AMICUS THERAPEUTICS, INC. CFO Sell 92.5 +29,259 7.68% ✗ $355.4K
Jan 4, 2023 Jan 6, 2023 AMICUS THERAPEUTICS, INC. CFO Sell 26.3 -3,884 -1.01% ✗ $46.7K
Jan 2, 2023 Jan 4, 2023 AMICUS THERAPEUTICS, INC. CFO Sell 97.5 +49,768 14.84% ✗ $287.5K
Sep 1, 2022 Sep 6, 2022 AMICUS THERAPEUTICS, INC. CFO Sell 48.8 -4,397 -1.29% ✓ $49.6K
Aug 5, 2022 Aug 9, 2022 AMICUS THERAPEUTICS, INC. CFO Sell 45.0 -5,798 -1.68% ✓ $69.6K
Jun 17, 2022 Jun 21, 2022 AMICUS THERAPEUTICS, INC. CFO Sell 48.8 -4,396 -1.26% ✓ $39.6K
Jan 14, 2022 Jan 19, 2022 AMICUS THERAPEUTICS, INC. CFO Sell 90.0 +17,997 5.42% ✗ $198.4K
Dec 31, 2021 Jan 4, 2022 AMICUS THERAPEUTICS, INC. CFO Sell 97.5 +41,277 14.20% ✗ $372.6K
Mar 5, 2021 Mar 9, 2021 AMICUS THERAPEUTICS, INC. CFO Sell 26.3 -4,664 -1.69% ✗ $48.9K
Jan 15, 2021 Jan 20, 2021 AMICUS THERAPEUTICS, INC. CFO Sell 82.5 +4,732 1.86% ✗ $104.2K
Dec 31, 2020 Jan 5, 2021 AMICUS THERAPEUTICS, INC. CFO Sell 90.0 +10,294 4.21% ✗ $527.3K
Dec 21, 2020 Dec 23, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 41.3 -5,000 -2.01% ✓ $120.5K
Dec 15, 2020 Dec 17, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 22.5 -4,156 -1.67% ✗ $99.2K
Oct 1, 2020 Oct 5, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 41.3 -5,000 -2.36% ✓ $70.1K
Jul 1, 2020 Jul 6, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 37.5 -6,872 -3.21% ✓ $106.3K
Jun 15, 2020 Jun 17, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 36.3 -1,046 -0.54% ✗ $11.7K
Jan 10, 2020 Jan 14, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 90.0 +12,431 6.98% ✗ $114.1K
Jan 9, 2020 Jan 10, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 28.8 -15,000 -8.24% ✓ $149K
Jan 2, 2020 Jan 6, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 22.5 -12,418 -6.39% ✗ $116.6K
Dec 31, 2019 Jan 3, 2020 AMICUS THERAPEUTICS, INC. CFO Sell 95.0 +65,133 50.39% ✗ $65.6K
Jun 17, 2019 Jun 18, 2019 AMICUS THERAPEUTICS, INC. CFO Sell 36.3 -1,046 -0.80% ✗ $11.9K
Jan 2, 2019 Jan 10, 2019 AMICUS THERAPEUTICS, INC. CFO Sell 91.3 +53,621 83.35% ✗ $39.8K
Mar 9, 2018 Mar 12, 2018 AMICUS THERAPEUTICS, INC. SVP, Finance Sell 25.0 -8,750 -11.97% ✓ $131.3K
Mar 1, 2018 Mar 5, 2018 AMICUS THERAPEUTICS, INC. SVP, Finance Sell 25.0 -8,149 -11.24% ✓ $114.5K
Jan 3, 2018 Jan 5, 2018 AMICUS THERAPEUTICS, INC. SVP, Finance Sell 91.3 +9,656 17.66% ✗ $46.3K
Jan 2, 2018 Jan 4, 2018 AMICUS THERAPEUTICS, INC. SVP, Finance Sell 25.0 -8,000 -12.76% ✓ $117.7K
Oct 12, 2017 Oct 16, 2017 AMICUS THERAPEUTICS, INC. SVP, Finance Sell 25.0 -7,000 -11.35% ✓ $99.7K
Nov 9, 2016 Nov 10, 2016 AMICUS THERAPEUTICS, INC. SVP, Finance Sell 20.0 -8,546 -15.01% ✓ $68.4K